0.0114
0.0021 (22.58%)
0.0021 (22.58%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioRestorative Therapies Inc (PK) | BRTX | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0021 | 22.58% | 0.0114 | 16:25:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0097 | 0.0096 | 0.018 | 0.0114 | 0.0093 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.0101 | 0.0115 | 0.0014 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,234 | 105,228,426 | $ 0.011201 | $ 1,178,695 | - | 0.0001 - 0.0336 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:08:34 | average | 9,561,198 | $ 0.01105 | USD |
BioRestorative Therapies (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 32.63M | 2.86B | 6.98M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 1.00 | $ - | 0.00% | - | - |
BioRestorative Therapies (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0067 | 0.018 | 0.0066 | 0.008425 | 32,428,691 | 0.0047 | 70.15% |
| 1 Month | 0.0071 | 0.018 | 0.0047 | 0.0077249 | 41,130,501 | 0.0043 | 60.56% |
| 3 Months | 0.033 | 0.0336 | 0.0047 | 0.0110227 | 49,930,416 | -0.0216 | -65.45% |
| 6 Months | 0.033 | 0.0336 | 0.0047 | 0.0110227 | 49,930,416 | -0.0216 | -65.45% |
| 1 Year | 0.006 | 0.0336 | 0.0001 | 0.003978 | 71,461,964 | 0.0054 | 90.0% |
| 3 Years | 3.20 | 4.00 | 0.0001 | 0.008703 | 11,461,505 | -3.19 | -99.64% |
| 5 Years | 3.15 | 5.01 | 0.0001 | 0.0092243 | 6,778,005 | -3.14 | -99.64% |
BioRestorative Therapies (PK) Description
| We develop therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs are: -- Disc/Spine Program (brtxDISCTM): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous cultured mesenchymal stem cells collected from bone marrow. We intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have received clearance from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. -- Metabolic Program (ThermoStem): We are developing a cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue ("BAT"). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes. |
